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The incidence of myocardial ischemia-reperfusion (IR) injury is rapidly increasing around
the world and this disease is a major contributor to global morbidity and mortality. It
is known that regulation of programmed cell death including apoptosis and autophagy
reduces the impact of myocardial IR injury. In this study, the cardioprotective effects and
underlying mechanisms of Phellinus linteus (Berk. and Curt.) Teng, Hymenochaetaceae
(PL), a type of medicinal mushroom, were examined in rats subjected to myocardial
IR injury. The left main coronary artery of rats was ligated for 1 h and reperfused for
3 h. The arrhythmia levels were monitored during the entire process and the infarct size
was evaluated after myocardial IR injury. Furthermore, the expression levels of proteins
in apoptotic and autophagic pathways were observed. Pretreatment with PL mycelium
(PLM) significantly reduced ventricular arrhythmia and mortality due to myocardial IR
injury. PLM also significantly decreased myocardial infarct size and plasma lactate
dehydrogenase level after myocardial IR injury. Moreover, PLM administration resulted
in decreased caspase 3 and caspase 9 activation and increased Bcl-2/Bax ratio.
Phosphorylation level of AMPK was elevated while mTOR level was reduced. Becline-1
and p62 levels decreased. These findings suggest that PLM is effective in protecting the
myocardium against IR injury. The mechanism involves mediation through suppressed
pro-apoptotic signaling and regulation of autophagic signaling, including stimulation of
AMPK-dependent pathway and inhibition of beclin-1-dependent pathway, resulting in
enhancement of protective autophagy and inhibition of excessive autophagy.
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INTRODUCTION
Myocardial ischemia is caused by a lack of coronary blood supply
to the heart. During myocardial ischemia, a characteristic pattern
of metabolic and ultrastructural changes leads to irreversible
injury. To limit myocardial infarct size and reduce mortality,
early restoration of blood flow to the ischemic myocardium is
a common treatment strategy (Schofield et al., 2013). However,
the return of blood flow can cause additional cardiac damage and
complications, such as paradoxical increases in infarct size and
induction of arrhythmia. This is known as myocardial ischemia-
reperfusion (IR) injury (Yellon and Hausenloy, 2007; Folino et al.,
2013). Incidence of myocardial IR injury is rapidly increasing
around the world and this disease is a major contributor to global
morbidity and mortality (Hausenloy and Yellon, 2013; Mozaffari
et al., 2013). Decreasing the impact of myocardial IR injury is
important in the prevention and treatment of ischemic heart
disease.
Recent studies have shown that myocardial cell death is the
main reason for the poor prognosis of patients with ischemic
heart disease. Ischemic and reperfusion injuries to the heart cause
various types of cardiomyocyte death such as necrosis, apoptosis,
and autophagy (Tian et al., 2013). Among these cell death types,
apoptosis (nuclear fragmentation, plasma membrane blabbing,
cell shrinkage and loss of mitochondrial membrane potential
and integrity) and autophagy (cytoplasmic vacuolization, loss
of organelles and accumulation of vacuoles with membrane
whorls) are the two principal pathways of programmed cell death.
These, may also be important pathways in myocardial IR injury
(Eltzschig and Eckle, 2011; Jennings, 2013).
It has been reported that crosstalk exists between apoptosis
and autophagy (Maiuri et al., 2007). Activation of autophagy leads
to removal of damaged organelles and phagocytic clearance of
apoptotic cells (Qu et al., 2007). Autophagy, a cellular process
associated with degradation and recycling of damaged organelles
and long-lived cytosolic protein, is activated in the heart during
normal physiological state and further stimulated under stress
conditions such as myocardial IR injury (Mizushima et al., 2008).
Under physiologic conditions, autophagy exists at low levels,
playing a protective role by degrading damaged mitochondria
and protein aggregates. However, excessive autophagy under
pathologic conditions can lead to organ dysfunction due
to degradation of essential proteins and organelles. These
conditions can include IR, nutrient deprivation, infection,
hypoxia, and mitochondrial dysfunction (Mizushima et al.,
2008). During autophagy, cytoplasmic organelles and proteins,
including mitochondria, endoplasmic reticulum (ER), Golgi
complex, and endosomes are surrounded and sequestered by
isolation membrane and nascent membranes fused at their
edges. These form autophagosomes, which subsequently undergo
a stepwise maturation process. During this process, there is
fusion with lysosomes, resulting in the delivery of cytoplasmic
contents to lysosomal components. Finally, there is degradation
and recycling (Kang et al., 2011). Defective autophagy can
influence cellular functions related to different diseases (Levine
and Klionsky, 2004). Cells can recycle extracted amino acids
and fatty acids for energy production and sequester damaged
organs during autophagy to prevent release of reactive oxygen
species (ROS) (Levine and Klionsky, 2004; Sciarretta et al.,
2011). However, cell death may be induced by excessive
activation (Mizushima et al., 2008; Yu et al., 2010). In brief,
insufficient or excessive autophagy is a possible mechanism of
disease.
Phellinus linteus (Berk. and Curt.) Teng, Hymenochaetaceae
(PL), a well-established medicinal mushroom, has been used
in Asian countries for centuries to prevent or treat ailments
as diverse as hemorrhage, rheumatoid arthritis, gastroenteric
dysfunction, diarrhea, and cancers. A number of studies have
revealed that PL alleviates septic shock and has antitumor
(Kim et al., 2003; Zhu et al., 2007; Park et al., 2010;
Konno et al., 2015), immunomodulatory (Song and Park, 2014;
Lin et al., 2015; Suabjakyong et al., 2015), anti-angiogenic
(Sliva et al., 2008; Lee et al., 2010), and antioxidant properties
(Lee et al., 2011, 2015). Moreover, in rats intraperitoneally
administered filtrate of PL broth culture, dose-dependent
decreases in cortical infarct volume have been demonstrated
following permanent focal cerebral ischemia (Suzuki et al.,
2011). From these findings, PL may have a beneficial effect
on ischemic tissue injury. In addition, hispidin, a phenolic
compound from PL, protects H9c2 cardiomyoblast cells and
neonatal rat ventricular myocytes against oxidative stress-
induced apoptosis. In addition, hispidin scavenges intracellular
ROS and increases heme oxygenase-1 and catalase expressions
(Kim et al., 2014). There have been no studies to date on
the effects of PL mycelium (PLM) on myocardial IR injury
in vivo or the molecular mechanism involved in such effects.
Therefore, we ligated coronary artery in rats for 1 h of
ischemia followed by 3 h of reperfusion to evaluate the effects
of PLM on myocardial IR injury. Rats were divided into
treatment and control groups. Comparisons were carried out
between groups. These comparisons included the durations
and incidences of ventricular tachycardia (VT) and ventricular
fibrillation (VF), as well as infarct size and mortality. We also
investigated the cardioprotective effects of PLM on signaling
pathways involved in autophagy. In the present study, the
aim was to explore the potential of PLM for protecting
against myocardial IR injury in vivo, as well as the underlying
mechanisms.
MATERIALS AND METHODS
Animals
Sprague-Dawley rats (LASCO Co., Charles River Technology,
Taipei, Taiwan), each weighing 250–300 g, were used. In this
study, based on the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH
Publication No. 85–23, revised 1996). The animal study protocol
was approved by the Institutional Animal Ethics Committee
of Taipei Veterans General Hospital, Taipei, Taiwan (IACUA
2015-241). Animals were housed under conditions of controlled
temperature (24 ± 1◦C) and humidity (55 ± 5%), as well as 12-h
light–dark cycle. Rats were allowed ad libitum access to food and
water.
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Experimental Design
The rats were randomly assigned to three groups: (1) sham;
(2) myocardial IR (control); (3) PLM treatment (PLM). The
experimental animals were administered PLM at a dosage of
10−8 or 10−9 g/kg via jugular vein 15 min prior to left anterior
descending artery (LAD) ligation under urethane anesthesia as
previously described. The sham and control animals were treated
with normal saline. LAD was ligated for 1 h and then reperfused
for 3 h. At the end of the experiment, rat hearts were harvested
to evaluate infarct size and protein expression levels by triphenyl
tetrazolium chloride (TTC) staining and immunoblotting.
Phellinus linteus Mycelium (PLM)
Preparation
Phellinus linteus mycelium was supplied by Chiu-Yeh WU’s lab
(Chuang Chou University of Science and Technology, Changhua
County, Taiwan) and prepared as previously described (Wu
et al., 2012). P. linteus, kindly supplied by Baoji Biotechnology
Company Limited, Nantou city, Nantou county, Taiwan, and had
been identified by Bioresource Collection and Research Center,
Hsinchu, Taiwan, was employed for the production of mycelial
biomass and bioactive compounds. The stock culture was
inoculated on potato dextrose agar (PDA, Himedia Laboratories,
Mumbai, India) slants and incubated at 30◦C for 14 days and then
stored at 4◦C.
To prepare the experimental inoculant, the microorganism
was initially grown on PDA plates, and then transferred to
the inoculum medium by punching out six pieces of 1 cm2 of
the agar plate culture with the sterilized cutter. The inoculum
culture was incubated in a 300 ml baﬄed flask containing 100 ml
potato dextrose broth (PDB, Himedia Laboratories, Mumbai,
India) under 30◦C, 100 rpm on a rotary shaker incubator for
24 h. The production culture in a stirred-tank bioreactor (Model
FMT-5L, Yuh Chuen Chiou Ind. Co., Ltd., Kaohsiung, Taiwan)
for PL was carried out on the fermentation medium compositions
(w/v): dextrose 2%, peptone 0.1% and malt extract 2%, and was
sterilized at 121◦C for 30 min. Fermentations were carried out
with 3 L fermentation medium under the following conditions:
inoculum ratio 5%, temperature 30◦C, aeration rate 1.5 vvm
and agitation rate 125 rpm. The cultivation was maintained for
20 days after the inoculum was transferred to the medium. After
finishing cultivation, the harvest of mycelial biomass were filtered
by filter paper, and then the resulting precipitate was washed
repeatedly by ddH2O and dried at 50◦C to a constant weight. 50 g
dried mycelia biomass was extracted by 500 mL ddH2O at 121◦C
for 15 min, cooled down, and filtered, and this step was repeated
twice. The filtrate was collected and condensed by lyophilized.
The powder was dissolved and dilute to working concentration
(10−8 and 10−9 g/kg) with normal saline.
Surgical Procedure
Temporary occlusion of the left main coronary artery was carried
out to induce myocardial IR injury, as previously described
(Huang et al., 2005). Briefly, urethane was used to anesthetize the
rats (1.25 g/kg, i.p.). After the trachea was cannulated to provide
artificial respiration, polyethylene catheters (PE-50) were placed
in the common carotid artery. There was continuous monitoring
of heart rate (HR) and arterial blood pressure (BP) via sensors.
Data were displayed on a data acquisition unit (MP35) and
physiological recorder (BIOPAC Systems, Inc., Goleta, CA, USA).
Silver electrodes were attached to the extremities for recording of
standard lead-1 ECG.
A respirator for small rodents (Model 131, NEMI, USA)
was used for ventilation with room air. Stroke volume was set
at 10 ml/kg body weight and stroke rate at 60 strokes/min.
Following sectioning of the fourth and fifth ribs, at 2 mm to the
left of the sternum, left thoracotomy was carried out to open up
the chest. Subsequently, the heart was quickly externalized and
inverted. Following placement of 6/0 silk ligature around the left
main coronary artery, The animal was allowed 15 min of recovery
following repositioning of the heart in the chest. If there was
arrhythmia or sustained decrease in BP to less than 70 mmHg
following the procedure, the animal was excluded from the study.
Evaluation of Arrhythmia
Antiarrhythmic effects of PLM during myocardial IR injury were
analyzed. Changes in HR, BP, and ECG were simultaneously
recorded on a personal computer with waveform analysis
software (AcqKnowledge, Biopac System, Goleta, CA, USA)
before and during ischemia and reperfusion. Ventricular
ectopic activity was evaluated based on Lambeth Convention-
recommended diagnostic criteria. Incidences and durations of
VT and fibrillation (VF) were determined in both surviving
rats and in those that eventually died. The duration of VF was
recorded until BP was lower than 15 mmHg in rats that died due
to irreversible VF.
Morphological Analysis
Rats were sacrificed at 4 h post-IR injury for infarct volume
analysis (TTC staining) (Bohl et al., 2009). Following removal,
the heart was perfused with cold saline solution for 5 min, and
flow rate was adjusted to the appropriate range, approximately
3 ml/min. Then, the crown artery was ligated again, followed by
perfusion with Evans blue, which stains the remote myocardium
but leaves the area at risk (AAR) unstained. Next, the heart
was sectioned into standard transverse slices of 2-mm thickness
using a heart matrix slicer (Jacobowitz Systems, Zivic-Miller
Laboratories Inc., Allison Park, PA, USA). Slices of the heart were
stained with vital dye TTC (2%; Sigma), first in the dark at 37◦C
for 30 min and, then, in 10% formalin at room temperature for
2 days. After scanning of infarcted tissue slices, the weights of
tissues were evaluated by distinguishing the blue colored remote
myocardium from the AAR and infarct area shown in white on
TTC staining assay.
Estimation of Myocardial Injury
Lactate dehydrogenase (LDH) activity in plasma was measured
to evaluate myocardial cellular damage. Following IR injury,
arterial blood was collected from the carotid catheter and mixed
with heparin (about 100 IU). LDH activity was determined
based on a previously described method (Tsai et al., 2004).
Following reduction of NAD to NADH by LDH, NADH interacts
with a specific probe, resulting in the production of color
Frontiers in Pharmacology | www.frontiersin.org 3 April 2017 | Volume 8 | Article 175
fphar-08-00175 April 5, 2017 Time: 16:50 # 4
Su et al. PLM Alleviates Myocardial IR Injury
(λmax = 450 nm) on colorimetric LDH quantification assay
(BioVision, Milpitas, CA, USA).
Immunoblotting
Left ventricle samples were homogenized with tissue protein
extraction reagent (Thermo, Waltham, MA, USA) containing
Protease Inhibitor Cocktail (Sigma-Aldrich, St. Louis, MO, USA).
Concentrations of proteins were quantified using a protein
assay dye reagent (Bio-Rad, Hercules, CA, USA) and bovine
serum albumin (BSA) as the standard. Following the mixing
with equal volumes of loading buffer [62.5 mM Tris-HCl, pH
6.8, 10% (v/v) glycerol, 2% SDS, 5% (v/v) 2-mercaptoethanol
and 0.05% (w/v) bromophenol blue], samples were heated to
95◦C for 10 min. They were then separated with SDS-PAGE
gel and transferred onto PVDF membranes (GE Healthcare,
Chicago, IL, USA). Blocking of membranes was achieved with
1% polyvinylpyrrolidone (PVP) and 0.05% tween 20 in phosphate
buffer solution (PBS) at room temperature for 1.5 h, followed
by incubation with primary antibodies including anti-Bcl2
(Abcam, Cambridge, MA, USA), anti-Bax (Abcam, Cambridge,
MA, USA), anti-caspase 3, anti-caspase 8, anti-caspase 9, and
anti-AMPKα and phospho -AMPKα, anti-phosphoinositide 3
kinase (PI3K) p85, anti-phospho PI3K p85, anti-phospho AKT
(Cell Signaling, Danvers, MA, USA). In addition, anti-mTOR,
anti-AKT (Spring Bioscience, Pleasanton, CA, USA) and
phospho -mTOR (Santa Cruz, Dallas, TX, USA); anti-LC3
(Novus Biologicals, Littleton, CO, USA); anti-beclin-1 (Novus
Biologicals, Littleton, CO, USA); anti-p62 (Novus Biologicals„
Littleton, CO, USA) and anti-β-actin (Sigma-Aldrich, St. Louis,
MO, USA) at 4◦C overnight. The membranes were washed
three times with PBS containing 0.1% tween-20 (PBST) followed
by horse radish peroxidase-conjugated secondary antibodies
(1:10,000 dilution) at 37◦C for 1 h. The blots were analzyed with
enhanced chemiluminescent system following additional PBST
washes.
Statistics
Data are expressed as mean ± standard error of mean (SEM).
Differences in IR-induced cardiac infarction and immunoblotting
were analyzed. The differences between IR control and PLM-
treated groups were ascertained by one-way analysis of variance.
The variables were subsequently analyzed to determine if there
were significant differences between the groups using Student’s
t-test. The differences in incidences of arrhythmia and mortality
between IR control and PLM-treated groups were analyzed on
Chi-square assay. Statistical significance was defined as p < 0.05.
All tests were two-tailed.
RESULTS
Hemodynamic Changes During Coronary
Artery Occlusion
Fifteen minutes after PLM administration via jugular vein
injection there were no significant alterations in mean arterial BP
or HR of anesthetized rats. In addition, there were no significant
hemodynamic changes between vehicle and PLM-treated groups
during 1-h myocardial ischemia and 3-h reperfusion periods
(Figures 1A,B).
Myocardial IR Induced Rhythm
Disturbances
Effects of PLM on anesthetized rats following myocardial
IR-elicited arrhythmia are presented in Table 1. The incidence
and duration of VT were 100% and 30.6 ± 10.8 s during
1 h myocardial ischemia and 3 h reperfusion in vehicle group.
Administration of 10−9 and 10−8 g/kg PLM resulted in a decrease
in the incidence of VT by 75%. In addition, the duration
of VT significantly decreased in PLM (10−9 and 10−8 g/kg)
treated groups by 4.5 ± 1.6 and 10.8 ± 3.8 s, respectively. The
incidence % of VF was 75% in vehicle-treated animals with
dose dependent decreases in PLM-treated groups (50 and 12.5%
in PLM 10−9 and 10−8 g/kg, respectively). Administration of
PLM also significantly improved the duration of VF. Duration
of VF was 41.8 ± 14.8 s in vehicle group, and significantly
decreased to 0.5 ± 0.2 s in 10−8 g/kg PLM-treated group.
VF is the severe type of arrhythmia and it is followed by
irreversible death. This phenomenon may imply that PLM
decreases myocardial IR-induced arrhythmia and mortality in a
dose-dependent manner.
Myocardial Infarct Size
Changes in myocardial infarct size in control rats and rats
administered PLM are shown in Figure 2. Evans blue colored
remote myocardium blue but not the AAR and infarct area, which
are shown in white on TTC analysis (Figure 2A). There are
no significant difference among the vehicle, 10−9 and 10−8 g/kg
PLM. AAR/ left vetrcle (LV; %) demonstrated that the IR model
is consistent in our study (Figure 2B). Infarct size/AAR % was
reduced in PLM 10−8 g/kg-treated group (28.02 vs. 12.70%,
P < 0.05) (Figure 2C). The acivity of plasma LDH, a marker
of tissue damage, was significant decreased in PLM group
(5489 ± 3389 vs. 1718 ± 182 mU/ml) (Figure 2D). Hence,
administration of PLM decreased the impact of myocardial IR
injury.
PLM Attenuates Myocardial IR-Induced
Apoptosis
Apoptotic cell death often occurs in cardiomyocytes after
myocardial IR injury. We investigated the expressions of Bcl-2
family proteins and caspase 3, 9, and 8 to assess the anti-apoptotic
effects of PLM in rats subjected to myocardial IR injury
(Figure 3A). Results demonstrated that PLM treatment increases
protein expression of Bcl-2, significantly reduces Bax expression
and increases ratio of Bcl-2 to Bax in the myocardium after
myocardial IR injury when compared with control.
Caspase 3 is a key protein in apoptotic cells, both in extrinsic
and intrinsic pathways. Thus, we used it to quantify the apoptotic
level in the heart after IR injury (Figure 3B). Both the pro-form
and active form (cleaved form) of caspase 3 were reduced in
PLM-treated group when compared with control. In addition,
PLM treatment significantly reduced the ratio of active form to
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FIGURE 1 | Lack of hemodynamic changes during coronary artery occlusion and reperfusion in control and PLM-treated groups. (A) Heart rate change
in vehicle (open circle, n = 10) and 10-8 g/kg (close circle, n = 11) PLM-treated groups during myocardial ischemia for 1-h followed by reperfusion for 3-h in rats.
(B) Mean arterial blood pressure change in vehicle (open circle, n = 10) and 10-8 g/kg (close circle, n = 11) PLM-treated groups during myocardial IR in rats. Each
experimental group is comprised of 10 rats. Results are expressed as mean ± SEM. The differences between vehicle and PLM-treated animals were not statistically
significant (ANOVA). ‘Pre’ indicates before coronary ligation.
TABLE 1 | Effect of Phellinus linteus mycelium (PLM) on coronary ischemia 1 h-reperfusion 3 h (IR) induced arrhythmias in anesthetized rats.
Ventricular tachycardia Ventricular fibrillation Mortality
n Incidence (%) Duration (s) Incidence (%) Duration (s) (%)
Sham
Vehicle 4 – – – – –
PLM 10−7 g/kg 4 – – – – –
Operated (IR)
Vehicle (Control) 8 100 30.6 ± 10.8 75 41.8 ± 14.8 50
PLM 10−9 g/kg 8 75 4.5 ± 1.6∗ 50 29.5 ± 10.4 37.5
PLM 10−8 g/kg 8 75 10.8 ± 3.8 12.5∗ 0.5 ± 0.2∗ 0∗
Vehicle is in normal saline; n = number of experiments; values for duration of VT and VF are shown as the mean ± S.E.M. ∗Statistical difference at the level of P < 0.05
as compared with control.
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FIGURE 2 | Ischemia-reperfusion-induced cardiac infarction was rescued by PLM treatment. Normal saline or PLM 10-8 g/kg was administered to rats
15 min before coronal artery ligation. Infarct volumes were determined after 1-h ischemia and 3-h reperfusion. Myocardial infarct size was assessed by Evans
blue/2,3,5-triphenyltetrazolium chloride (TTC) double staining. Representative photographs of heart horizontal sections are shown (A). Blue-stained areas are
non-ischemic regions; red-stained areas are ischemic-reperfused but viable regions; white areas are infarcted regions. Mean ± SEM of quantitative risk zone
infarcted % (ratio of non-blue area to total area) (B), the infarct size/ AAR % (ratio of white area to non-blue area) (C), and plasma lactate dehydrogenase (LDH)
activity (D) in age-matched control (n = 8), and PLM-treated rats (PLM, n = 8). ∗P < 0.05 represents a significant difference between control and PLM-treated
groups. Values are expressed as mean ± SEM.
FIGURE 3 | Phellinus linteus mycelium deceased apoptosis after IR injury. Representative Western blots show the levels of Bcl-2, Bax (A), full length and
cleaved caspase 3 (B) and full length and cleaved caspase 9 and 8 (C) in heart tissue. Graphs represent the quantitative differences between control and
PLM-treated groups. β-actin was used as a loading control for the blots. ∗P < 0.05 represents a significant difference between control and PLM-treated groups.
Values are expressed as mean ± SEM (n = 3).
pro-form of caspase 3 when compared with control. In PLM
treated group, it was also shown the ratio of active form of caspase
9 was decreased, but active form of caspase 8 did not change
significantly (Figure 3C). These results indicated that PLM
attenuates apoptotic level via intrinsic pathway in IR-injured
heart.
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FIGURE 4 | Phellinus linteus mycelium increased autophagy after IR injury. Representative Western blots show the levels of phosphoric AMPK (A)
phosphoric mTOR (B), LC3I/II ratio (C), beclin-1 (D), and p62 (E) in heart tissue. Graphs represent the quantitative differences between the control and PLM-treated
groups. β-actin was used as a loading control for the blots. ∗P < 0.05 represents significant difference between control and PLM-treated groups. Values are
expressed as mean ± SEM (n = 3).
PLM Regulates Myocardial IR-Induced
Autophagy
To examine the role of autophagy in the cardioprotective effect
of PLM, we investigated the phosphorylation levels of AMPK
and mTOR (p-AMPK and p-mTOR) in left heart ventricle
(Figures 4A,B). Immunoblotting revealed that treatment with
PLM significantly increases the ratio of p-AMPK to AMPK
expression and reduces the ratio of p-mTOR to mTOR expression
in IR injured myocardium when compared with control.
Regulation of autophagy by mTOR-dependent pathways also
could be adjusted by PI3K-AKT pathway (Karki et al., 2016).
Hence, we observed the phosphorylation levels of PI3K and
AKT (p-PI3K and p-AKT) in left heart ventricle (Supplementary
Figures 1A,B). However, the activation of PI3K and AKT had no
significantly diffence bteewn control and PLM treated group.
LC3 is widely used to monitor autophagy. LC3-I is the
cytosolic form. LC3-II is conjugated with phosphatidylet-
hanolamine (PE) and is present in isolation membranes,
autophagosomes, and to a much lesser degree in autolysosomes.
In our experiments, when compared with control group, LC3-I
did not change in the PLM-treated group. The expression of
LC3-II and the ratio of LC3-II to LC3-I increased in PLM-treated
group, but this increase did not reach significance (Figure 4C).
However, beclin-1, a major protein in the nucleation step
of autophagy, and p62, a protein targeting specific cargo of
autophagy (Rusten and Stenmark, 2010), significantly decreased
in PLM-treated group (Figures 4D,E). Beclin-1 autophagy
induction pathway is regarded as deleterious during IR injury
(Ma et al., 2015), and cannot be suppressed by Bcl-2. Bcl-2/beclin-
1 interaction is an important checkpoint in autophagic induction
due to starvation or treatment with autophagy inducers. The ratio
of Bcl-2 to beclin-1 increased in PLM-treated group (1.13 ± 0.15
vs. 1 1.85 ± 0.23, P < 0.05). These findings suggested that PLM
regulates autophagy through stimulation of AMPK-dependent
mechanism and inhibition of beclin-1-dependent mechanism in
rats after myocardial IR injury.
DISCUSSION
This is the first study to examine the cardioprotective effects of
PLM in rats subjected to myocardial IR injury. PLM did not alter
the mean arterial BP or HR in studied rats. Figure 5 summarized
the effect of PLM in this study. In the ischemic border zone,
the leakage of potassium increased extracellular potassium
and caused depolarization of myocytes. This depolarization
contributes to electrical heterogeneity of conduction that provide
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FIGURE 5 | Schematic diagram of the effects of PLM against myocardial IR injury. PLM caused apoptotic decrease via increasing ratio of Bcl-2 and Bax.
Beclin-1 decreased to attenuate excessive autophagy and the activity of mTOR was downregulated to enhance protective autophagy. Decreased apoptosis and
regulation of autophagy play protective roles in myocardial IR injury.
a substrate for reentry, bring about polymorphic VT and/or VF
(Koplan and Stevenson, 2009). Administration of PLM effectively
suppressed the durations of VT and VF and the incidence of
VF at dose of 10−8 g/kg, during 1-h myocardial ischemia and
3-h reperfusion period. In addition, myocardial infarction was
significantly reduced in PLM-treated group. Compared with
control group, LDH activity, which serves as an indicator of
cellular damage in plasma, significantly decreased in PLM-treated
group during myocardial IR injury, which is consistent with
the observation of decreased myocardial infarction. The results
of this study support the potential application of PLM as a
cardioprotective agent in myocardial IR injury.
Apoptosis, as well as necrosis, often occurs in cardiomyocytes
after myocardial IR injury. In the myocardial ischemic core,
which is completely deprived of oxygen and nutrients,
myocardium dies due to necrosis. However, in the ischemic
penumbra, where there is hypoxia after myocardial IR injury,
reperfusion accelerates the process of apoptosis compared with
permanent occlusion and myocardial cell death occurs via both
necrosis and apoptosis (Whelan et al., 2010; Chen-Scarabelli
et al., 2014). In this study, we conducted immunoblotting of
Bcl2, an antiapoptotic protein, and Bax, a proapoptotic protein.
Pro-form and active form (cleaved form) of caspase 3 were also
used to assess the effects of PLM on apoptosis. We found that
PLM reduced the expression level of Bax, increased the ratio
of Bcl-2/Bax and reduced active caspase 3. Furthermore, PLM
decreased activation of caspase 9, the intrinsic apoptotic caspase;
but not caspase 8, the extrinsic apoptotic caspase. This data
meant that PLM reduced the apoptosis relating to mitochondria
malfunction. These findings suggest that the inhibition of
intrinsic apoptosis contributes to the underlying beneficial effect
of PLM.
Several studies have reported that myocardial cell death
during IR injury occurs by apoptosis, by necrosis and in
association with autophagy (Glick et al., 2010; Whelan et al.,
2010; Chen-Scarabelli et al., 2014; Gatica et al., 2015).
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Autophagy is an important intracellular self- degradation
process which is activated by myocardial IR injury. However,
whether autophagy plays a beneficial or deleterious role during
myocardial IR injury is still unclear (Rifki and Hill, 2012).
Autophagy is essential in cellular energy mobilization and
homeostasis. However, excessive autophagy leads to progressive
consumption of cellular constituents and autophagic cell
death. In cardiomyocytes, PT1, AMPK agonist, and 3HOI-
BA-01, mTOR inhibitor, profoundly upregulate autophagy in
cardiomyocytes after oxygen glucose deprivation/reoxygenation
and significantly promote cardiomyocyte survival. In addition,
administration of PT1 and 3HOI-BA-01 significantly decreases
infarct size in murine myocardial IR injury (Huang et al.,
2016). Nevertheless, in adult male Sprague-Dawley rats, ischemic
preconditioning that includes three cycles of regional ischemia
at 5 min each, with alternating cycle of 5 min reperfusion,
inhibits beclin-1-dependent excessive autophagy and diminishes
cell death induced by myocardial IR injury (Peng et al.,
2013). The classical pathways of autophay are beclin-1-
mediated autophagy/apoptosis and AMPK-mTOR-mediated
mTOR/autophagy mutual feedback signaling. Excessive beclin-
1 protein expression during myocardial IR injury may result
in an autophagic imbalance that leads to cell death while
induction of autophagy via activation of AMPK is beneficial.
Matsui et al. (2007) also reported that autophagy plays distinct
roles during myocardial ischemia and IR. Myocardial ischemia-
stimulated autophagy through AMPK-dependent mechanism
may be protective, whereas IR-stimulated autophagy through
beclin-1-dependent, but AMPK-independent, mechanism may
be detrimental (Matsui et al., 2007). The activation of AMPK
inhibits mTOR-dependent signaling, leading to activation of
autophagy. In this study, we found that PLM increases the
activity of AMPK and suppresses mTOR activity. These results
suggest that PLM increases the activation of AMPK to enhance
autophagy by mTOR suppression. Due to the degradation of
autophagosomes, beclin-1 and p62 were significantly degraded
after 1-h ischemia and 3-h reperfusion injury. These findings
indicate that PLM regulates autophagy through stimulation
of AMPK-dependent mechanism and inhibition of beclin-1-
dependent mechanism in rats after myocardial IR injury.
In others researches, it was reported that mTOR manipulate
the autophagy was not only regulated by AMPK but also by
PI3K-AKT pathway (Karki et al., 2016). In physiological and
pathological conditions, PI3K-AKT pathway was crucial to many
aspects of cell growth and survival, and which was initiated by
receptor tyrosine kinases (RTK) or G-protein–coupled receptors
(GPCRs), which located at the cell surface and activated by many
kinds of growth factors. (Pyne and Pyne, 2011; Dienstmann
et al., 2014). In this study, the expressions of PI3K and AKT
were not influenced significantly by PLM treated (Supplementary
Data). It might imply that the effect of mTOR-autophagy by PLM
treatment was independent to PI3K-AKT pathway.
Several studies have demonstrated that Bcl-2, an antiapoptotic
protein, inhibits beclin-1 via direct binding. This indicates that
there is negative regulation of beclin-1-mediated autophagy
by Bcl-2, and crosstalk between autophagy and apoptosis
(Chen-Scarabelli et al., 2014; Ma et al., 2015). In this
study, we found that PLM treatment significantly increases
the ratio of Bcl-2 to beclin-1. PLM inhibits apoptosis by
upregulation of Bcl-2 expression and downregulation of beclin-
1 expression. Therefore, PLM simultaneously inhibits apoptosis
and excessive autophagy via the modulation of Bcl-2/beclin-
1expression.
In this study, we administrate the PLM, not the fruiting body,
before myocardial IR injury. In mycelia of PL, the content of
protein, amino acid, total sugar, reducing sugar, polysaccharide
and saturated fatty acid were more abundant as compared with
the fruiting body (Chen et al., 2016). There are several literatures
to reported that polysaccharides might play an important role
in the activity of alleviating the myocardial IR injuries (Lu
and Zhao, 2010; Zhang et al., 2013). The mycelial culture
of PL was be found its polysaccharide might have effect on
anti-inflammation, which was believed that it resulted from
the structures of the high molecule weight could stimulate
the reticulo-endothelial system (Song et al., 1995; Baker et al.,
2008). Antioxidant such as hispidin was found in PLM (Chen
et al., 2016). Hispidin was identified and could scavenge the
free radicals (Lee and Yun, 2007; Jung et al., 2008). The anti-
inflammatory and antioxidative effects of PLM could contribute
to the cardioprotective effect against IR injury and decrease cell
programmed death.
CONCLUSION
Our results indicated that PLM attenuates myocardial IR injury.
The cardioprotective effect of PLM may be mediated via
inhibition of apoptosis and regulation of autophagy, stimulation
of AMPK-dependent mechanism and inhibition of beclin-1-
dependent mechanism in rats subjected to myocardial IR injury.
The findings of this study suggest that the administration of PLM
prior to myocardial IR injury is a potential approach for the
treatment of IR injury.
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